![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Adocia reports 2012 revenue multiplied by 2.5 with a strong cash position
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines with already...
Sanofi delivers solid 2012 results despite patent expirations
In the fourth quarter of 2012, Sanofi generated sales of €8,526 million, an increase...
Roche delivers strong 2012 results
Roche delivered a strong performance in 2012, with Group sales rising 4% to 45.5...
AstraZeneca fourth quarter and full year results 2012
AstraZeneca's revenue in the fourth quarter was down 15 percent at constant exchange rates...
Bristol-Myers Squibb reports fourth quarter financial results
Bristol-Myers Squibb Company has announced results for the fourth quarter of 2012 highlighted by...
Pivotal Therapeutics reports third quarter 2012 financial results
Pivotal Therapeutics Inc. , a specialty pharmaceutical company with a focus on cardiovascular disease...
Hybrigenics 2012 first-half results
Plus 5 per cent growth of Hybrigenics’ operating revenues An...
Johnson & Johnson Reports 2012 Third-Quarter Results
Sales of $17.1 Billion increased 6.5% Versus 2011 Third Quarter; Third-Quarter EPS was $1.05...
Roche Group posts strong sales growth in the third quarter
Roche sales grew 4% to 33.7 billion Swiss francs thanks to strong demand for...
BIOGEN IDEC TO REPORT THIRD QUARTER 2012 FINANCIAL RESULTS ON OCTOBER 25, 2012
Biogen Idec Inc. today announced it will report third quarter 2012 financial results on Thursday,...